Telesta Therapeutics Inc logo

TST - Telesta Therapeutics Inc Share Price

C$0.13 0.0  0.0%

Last Trade - 01/11/16

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £7.50m
Position in Universe th / 2681
Bullish
Bearish
Unlock TST Revenue
Momentum
Relative Strength (%)
1m -5.66%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
34.6 1.99 0.082 0.000 0.000 13.2 9.61 -17.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2016, TelestaTherapeutics Inc revenues increased from C$0K to C$13.2M.Net income before extraordinary items totaled C$3.8M vs.loss of C$14.4M. Revenues reflect an increase in demand forthe Company's products and services due to favorable marketconditions. Net Income reflects Other OperatingIncome/Expenses decrease from C$1.5M (expense) to C$10.1M(income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TST Revenue Unlock TST Revenue

Net Income

TST Net Income Unlock TST Revenue

Normalised EPS

TST Normalised EPS Unlock TST Revenue

PE Ratio Range

TST PE Ratio Range Unlock TST Revenue

Dividend Yield Range

TST Dividend Yield Range Unlock TST Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TST EPS Forecasts Unlock TST Revenue
Profile Summary

Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.

Directors
Last Annual June 30th, 2016
Last Interim June 30th, 2016
Incorporated September 1, 1999
No. of Shareholders: n/a
No. of Employees: 53
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Toronto Stock Exchange
Shares in Issue 303,506,029
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TST Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TST
Upcoming Events for TST
Frequently Asked Questions for Telesta Therapeutics Inc
What is the Telesta Therapeutics Inc share price?

As of 01/11/16, shares in Telesta Therapeutics Inc are trading at C$0.13, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Telesta Therapeutics Inc share price performed this year?

Shares in Telesta Therapeutics Inc are currently trading at C$0.13 and the price has moved by -75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Telesta Therapeutics Inc price has moved by -77.09% over the past year.

What are the analyst and broker recommendations for Telesta Therapeutics Inc?

Of the analysts with advisory recommendations for Telesta Therapeutics Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Telesta Therapeutics Inc is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Telesta Therapeutics Inc next release its financial results?

Telesta Therapeutics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2017-06-30
What is the Telesta Therapeutics Inc dividend yield?

Telesta Therapeutics Inc does not currently pay a dividend.

Does Telesta Therapeutics Inc pay a dividend?

Telesta Therapeutics Inc does not currently pay a dividend.

When does Telesta Therapeutics Inc next pay dividends?

Telesta Therapeutics Inc does not currently pay a dividend.

How do I buy Telesta Therapeutics Inc shares?

To buy shares in Telesta Therapeutics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Telesta Therapeutics Inc?

Shares in Telesta Therapeutics Inc are currently trading at C$0.13, giving the company a market capitalisation of £n/a.

Where are Telesta Therapeutics Inc shares listed? Where are Telesta Therapeutics Inc shares listed?

Here are the trading details for Telesta Therapeutics Inc:

Country of listing: Canada
Exchange: TOR
Ticker Symbol: TST
What kind of share is Telesta Therapeutics Inc?

We were not able to load our ranking data for Telesta Therapeutics Inc

Is there a Telesta Therapeutics Inc share price forecast 2021?

We were not able to load any forecast data for Telesta Therapeutics Inc.

How can I tell whether the Telesta Therapeutics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Telesta Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 48%. At the current price of C$0.13, shares in Telesta Therapeutics Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Telesta Therapeutics Inc PE Ratio?

We were not able to find PE ratio data for Telesta Therapeutics Inc.

Who are the key directors of Telesta Therapeutics Inc?

We were unable to find the directors for Telesta Therapeutics Inc.

Who are the major shareholders of Telesta Therapeutics Inc?

Here are the top five shareholders of Telesta Therapeutics Inc based on the size of their shareholding:

Similar to TST
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.